Patent Application for Implantable Sensors and Shunting Systems
Summary
The USPTO has published a new patent application (US20260083946A1) for implantable sensors and shunting systems. The application details a system for shunting blood between heart atria and includes a sensor with an actuation element to reduce tissue ingrowth. The filing date was December 3, 2025.
What changed
This document is a publication of a patent application filed with the USPTO, specifically application US20260083946A1, titled 'IMPLANTABLE SENSORS AND ASSOCIATED SYSTEMS AND METHODS'. The application describes a system for interatrial shunting, including a shunting element and an operably coupled sensor with an actuation mechanism designed to mitigate tissue ingrowth. The inventors listed are Brian Fahey, Amr Salahieh, Marwan Berrada, Tom Saul, and Peter Andriola.
As this is a patent application, it does not impose direct regulatory obligations or compliance deadlines on entities. However, it signifies potential future intellectual property developments in the medical device sector, particularly concerning cardiovascular implants and monitoring systems. Companies operating in this space should be aware of this filing as it may impact future product development and patent landscapes.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
IMPLANTABLE SENSORS AND ASSOCIATED SYSTEMS AND METHODS
Application US20260083946A1 Kind: A1 Mar 26, 2026
Inventors
Brian Fahey, Amr Salahieh, Marwan Berrada, Tom Saul, Peter Andriola
Abstract
The present technology relates to interatrial shunting systems and methods. In some embodiments, the present technology includes a system for shunting blood between a left atrium and a right atrium of a patient. The system can include a shunting element having a lumen extending therethrough. The lumen is configured to fluidly couple the left atrium and the right atrium when the shunting element is implanted in the patient. The system can also include a sensor configured to be implanted in the patient and operably coupled to the shunting element. An actuation element is coupled to the sensor. The actuation element is configured to be selectively energized and transmit a desired motion to the sensor to reduce the likelihood of tissue ingrowth/overgrowth and adhesion on at least a portion of the sensor.
CPC Classifications
A61M 27/002 A61M 2205/0266 A61M 2205/0294 A61M 2205/3324 A61M 2205/3344 A61M 2210/125
Filing Date
2025-12-03
Application No.
19407301
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Medical Devices (A61M)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Medical Devices (A61M) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.